These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4583506)

  • 1. Effects of contraceptive pill constituents on foetal mouse hearts.
    Hassan MM; Longmore DB
    Nature; 1973 Aug; 244(5415):349-51. PubMed ID: 4583506
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha fetoprotein levels in women taking oral contraceptives.
    Seppälä M
    Int J Fertil; 1973; 18(4):206-8. PubMed ID: 4359688
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clinical performance of three triphasic oral contraceptives: a multicenter, randomized comparative trial.
    Schilling LH; Bolding OT; Chenault CB; Chong AP; Fleury F; Forrest K; Glick HI; Hasson HM; Heil CG; London RS
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1264-8. PubMed ID: 2655451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of oral contraceptives on vitamin A metabolism in the human and the rat.
    Yeung DL
    Am J Clin Nutr; 1974 Feb; 27(2):125-9. PubMed ID: 4812928
    [No Abstract]   [Full Text] [Related]  

  • 10. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity.
    Schwartz U; Hammerstein J
    Acta Endocrinol (Copenh); 1974 May; 76(1):159-71. PubMed ID: 4406579
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
    Barbosa J; Seal US; Doe RP
    J Clin Endocrinol Metab; 1973 Apr; 36(4):706-14. PubMed ID: 4119677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen potencies of three new low-dose oral contraceptives.
    Dickey RP; Chihal HJ; Peppler RD
    Am J Obstet Gynecol; 1976 Aug; 125(7):976-9. PubMed ID: 941952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral progestogens on estrogen-induced changes in plasma proteins.
    Briggs MH
    J Reprod Med; 1975 Sep; 15(3):100-2. PubMed ID: 1214250
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of oral contraceptives on plasma renin activity and plasma renin substrate concentration (author's transl)].
    Kaulhausen H; Oehm W; Fritzsche G; Breuer H
    Z Klin Chem Klin Biochem; 1974 Sep; 12(9):408-14. PubMed ID: 4372825
    [No Abstract]   [Full Text] [Related]  

  • 16. Uterine response to prostaglandin e2 under oral contraceptives.
    Toppozada M; Khowessah M; Shaala S; Said S; Osman M
    Contraception; 1976 Jun; 13(6):749-61. PubMed ID: 1277847
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum vitamin A and retinol-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
    Mohan Ram M; Bamji MS
    Am J Obstet Gynecol; 1979 Oct; 135(4):470-2. PubMed ID: 573554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol.
    Mandal B; Maity CR
    Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial.
    Notelovitz M; Feldman EB; Gillespy M; Gudat J
    Am J Obstet Gynecol; 1989 May; 160(5 Pt 2):1269-80. PubMed ID: 2655452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen potency of oral contraceptive pills.
    Chihal HJ; Peppler RD; Dickey RP
    Am J Obstet Gynecol; 1975 Jan; 121(1):75-83. PubMed ID: 1115120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.